Protective effects of isoliquiritigenin against methamphetamine-induced neurotoxicity in mice

Journal of Pharmacological Sciences

Volumn 111, Issue 2, 2009, Pages 216-220

  Min, Jung Lee ^a   Chae, Ha Yang ^a   Jeon, Jae Pil ^b   Hwang, Meeyul ^a  

^a Daegu Haany University   (South Korea)

^b Korea National Institute of Health   (South Korea)

Author keywords

Isoliquiritigenin; Methamphetamine; Neurotoxicity

Indexed keywords

DOPAMINE TRANSPORTER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOLIQUIRITIGENIN; METHAMPHETAMINE; NITRIC OXIDE SYNTHASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE MODEL; DRUG INHIBITION; GLIA CELL; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN PHOSPHORYLATION; STRIATE CORTEX;

EID: 70350511470     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09153SC     Document Type: Article

References (15)

1. Hotchkiss AJ, Morgan ME, Gibb JW. The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci. 1979;25:1373-1378.
2. Stephans SE, Yamamoto BK. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse. 1994;17:203-209. (Pubitemid 24204347)
3. Michel PP, Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res. 1990;26:428-435. (Pubitemid 20261989)
4. Haughey HM, Fleckenstein AE, Hanson GR. Differential regional effects of methamphetamine on the activities of tryptophan and tyrosine hydroxylase. J Neurochem. 1999;72: 661-668. (Pubitemid 29055228)
5. Metzger RR, Haughey HM, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J Pharmacol Exp Ther. 2000;295:1077-1085. (Pubitemid 30951566)
6. DeVitro MJ, Wangner GC. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacol. 1989;28:1145-1150.
7. Wu PH, Shen YC, Wang YH, Chi CW, Yen JC. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum. Toxicology. 2006;226:238-245. (Pubitemid 44287163)
8. Jang E, Choe E, Kim S, Lee J, Kim S, Hwang M, et al. Isoliquiritigenin suppresses cocaine-induced extracellular dopamine release in rat brain through GABAB receptor. Eur J Pharmacol. 2008;587:124-128.
9. Jeon J, Buono RJ, Han B, Jang E, Kim S, Yang C, et al. Proteomic and behavioral analysis of response to isoliquiritigenin in brains of acute cocaine treated rats. J Proteome Res. 2008;7: 5094-5102.
10. O'Callaghan JP, Miller DB. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther. 1994;270:741-751.
11. Kim J, Park S, Yun K, Cho Y, Park H, Lee K. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. Eur J Pharmacol. 2008;584:175-184.
12. Takahashi T, Takasuka N, Iigo M, Baba M, Nishino H, Tsuda H, et al. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci. 2004; 95:448-453. (Pubitemid 38832690)
13. Itzhak Y, Ali SF. The neuronal nitric oxide synthase inhibitior, 7-nitroindazole, proteicts against methamphetamine-induced neurotoxicity in vivo. J Neurochem. 1996;67:1770-1773. (Pubitemid 26314238)
14. Albers DS, Sonsalla PK. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther. 1995;275:1104-1114.
15. Hozumi H, Asanuma M, Miyazaki I, Fukuoka S, Kikkawa Y, Kimoto N, et al. Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity. Toxicol Lett. 2008; 177:123-129.